等待开盘 10-17 09:30:00 美东时间
-2.565
-3.10%
Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR), a global healthcare company focused on developing medical devices to restore heart function, announced that its Vice Chairman and CEO, Wayne Paterson, will present at three major healthcare conferences: the Cantor Global Healthcare Conference on September 9, 2026, the Wells Fargo 21st Annual Healthcare Conference on September 10, 2026, and the Morgan Stanley 24th Annual Global Healthcare ...
08-31 18:45
Anteris Technologies Global Corp. reported Q2 2026 financial results and updates, highlighting key achievements including securing U.S. Medicare reimbursement for the PARADIGM Trial, initiating U.S. patient recruitment, expanding trial sites in multiple countries, appointing new Board members, and showcasing clinical progress at New York Valves 2026. The Company emphasized advancing the DurAVR® THV toward commercialization, supported by clinical,...
08-11 23:00
Transcat (NASDAQ:TRNS) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.38 by 34.21 percent. This is a 13.56 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $92.945 million which b...
08-05 04:03
Transcat (NASDAQ:TRNS) released fourth-quarter financial results and hosted an ...
05-27 05:13
Looking ahead, we remain optimistic about the trajectory of our service segment, underpinned by strong customer retention, rising activity levels, and the conversion of new business wins into revenue. We expect service
05-27 04:03
Transcat (NASDAQ:TRNS) reported quarterly earnings of $0.56 per share which met the analyst consensus estimate. This is a 12.5 percent decrease over earnings of $0.64 per share from the same period last year. The
05-27 04:01
Companies Reporting Before The Bell • Freightos (NASDAQ:CRGO) is projected to r...
05-26 19:11
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Transcat 2026财年第二季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 合并营收8,230万美元,同比增长21% - 服务业务营收同比增长20%,实现连续66个季度同比增长 - 分销业务营收2,940万美元,同比增长24% **盈利能力:** - 毛利润2,680万美元,同比增长26% - 合并毛利率扩张120个基点 - 分销业务毛利率扩张530个基点 - 调整后EBITDA为1,210万美元,同比增长37% **净利润:** - GAAP净利润130万美元,同比下降200万美元 - 稀释每股收益
05-26 12:07
Shares of industrial distribution companies are trading higher driven by easing...
04-09 03:15